Sbi Securities Co., Ltd. Ikena Oncology, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 3 shares of IKNA stock, worth $3. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$3% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IKNA
# of Institutions
55Shares Held
31.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$6.57 Million1.36% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$5.36 Million2.87% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$5.25 Million0.25% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.59MShares$4.7 Million3.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$4.64 Million0.16% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $47.5M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...